Effects of Dapagliflozin in Combination with Hydrochlorothiazide on Cardiac Remodeling in Rats with Heart Failure After Myocardial Infarction

被引:0
作者
Luo, Jinghong [1 ,2 ]
Li, Ling [3 ]
Zeng, Qingchun [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, 1838 Guangzhou Blvd N, Guangzhou 510080, Guangdong, Peoples R China
[2] Huizhou Cent Peoples Hosp, Ctr Sci Res, Dept Geriatr, Huizhou, Peoples R China
[3] Huizhou Cent Peoples Hosp, Dept Radiat Oncol, Huizhou, Peoples R China
关键词
Cardiac function; Oxidative stress; Inflammation; Sodium-hydrogen exchanger 1; Mechanism; NA+/H+ EXCHANGER; INHIBITION; EMPAGLIFLOZIN; HYPERTROPHY; MODEL; MICE;
D O I
10.1536/ihj.24-069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In addition to its antihypertensive and diuretic effects, hydrochlorothiazide also demonstrates additional cardioprotective properties; however, the existence of a synergistic interaction between dapagliflozin and hydrochlorothiazide remains unclear. To establish a rat model of heart failure for investigating the effects and mechanisms of dapagliflozin in combination with hydrochlorothiazide during early intervention, H9c2 cells were cultured to validate their in vitro efficacy. The combination group exhibits a synergistic improvement in hemodynamics, ejection fraction, and a reduction in plasma B-type natriuretic peptide concentration. This combination effectively decreases collagen volume fraction and the expression of collagen I and III, p47phox, p67phox, NF-kappa B p65, Bax, and caspase-3. The combination group demonstrates a synergistic effect in enhancing cardiac function, attenuating oxidative stress and inflammation. The in vitro effects of the combination were demonstrated in H9c2 cardiomyocytes. In addition, the combination exhibits a more pronounced inhibitory effect on NHE1 expression. The expression of NHE1 in H9c2 cells is inhibited by hydrochlorothiazide, thereby alleviating the consequences of NHE1 overexpression. The results of molecular docking and kinetic simulations indicate a strong binding affinity (-6.1 kcal/ mol) between hydrochlorothiazide and NHE1, resulting in the formation of a stable conformation. This may elucidate the underlying mechanism responsible for the synergistic effects of drugs. The combination of dapagliflozin and hydrochlorothiazide has synergistic effects on improving cardiac function, oxidative stress, and inflammation in rats with heart failure. Hydrochlorothiazide binds to and inhibits the expression of NHE1, thereby enhancing dapagliflozin's inhibitory effect on NHE activity. This mechanism potentially elucidates its enhanced cardioprotective effects.
引用
收藏
页码:913 / 928
页数:16
相关论文
共 32 条
  • [1] An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney
    Alarcon Arias, Simone Costa
    Souza, Renata Alves
    Avancini Costa Malheiros, Denise Maria
    Fanelli, Camilla
    Fujihara, Clarice Kazue
    Zatz, Roberto
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (02) : F135 - F143
  • [2] Phospholipase C-related catalytically inactive protein (PRIP) controls KIF5B-mediated insulin secretion
    Asano, Satoshi
    Nemoto, Tomomi
    Kitayama, Tomoya
    Harada, Kae
    Zhang, Jun
    Harada, Kana
    Tanida, Isei
    Hirata, Masato
    Kanematsu, Takashi
    [J]. BIOLOGY OPEN, 2014, 3 (06): : 463 - 474
  • [3] Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
    Baartscheer, Antonius
    Schumacher, Cees A.
    Wust, Rob C. I.
    Fiolet, Jan W. T.
    Stienen, Ger J. M.
    Coronel, Ruben
    Zuurbier, Coert J.
    [J]. DIABETOLOGIA, 2017, 60 (03) : 568 - 573
  • [4] Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension
    Ceron, C. S.
    Castro, M. M.
    Rizzi, E.
    Montenegro, M. F.
    Fontana, V.
    Salgado, M. C. O.
    Gerlach, R. F.
    Tanus-Santos, J. E.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (01) : 77 - 87
  • [5] LCZ696 Therapy Reduces Ventricular Tachyarrhythmia Inducibility in a Myocardial Infarction-Induced Heart Failure Rat Model
    Chang, Po-Cheng
    Lin, Shien-Fong
    Chu, Yen
    Wo, Hung-Ta
    Lee, Hui-Ling
    Huang, Yu-Chang
    Wen, Ming-Shien
    Chou, Chung-Chuan
    [J]. CARDIOVASCULAR THERAPEUTICS, 2019,
  • [6] Low shear stress induces endothelial reactive oxygen species via the AT1R/eNOS/NO pathway
    Chao, Yuelin
    Ye, Peng
    Zhu, Linlin
    Kong, Xiangquan
    Qu, Xinliang
    Zhang, Junxia
    Luo, Jie
    Yang, Hongfeng
    Chen, Shaoliang
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (02) : 1384 - 1395
  • [7] Manipulating cardiac contractility in heart failure - Data from mice and men
    Dorn, GW
    Molkentin, JD
    [J]. CIRCULATION, 2004, 109 (02) : 150 - 158
  • [8] Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects
    Dyck, Jason R. B.
    Sossalla, Samuel
    Hamdani, Nazha
    Coronel, Ruben
    Weber, Nina C.
    Light, Peter E.
    Zuurbier, Coert J.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 167 : 17 - 31
  • [9] Myocardial Interstitial Fibrosis in Heart Failure Biological and Translational Perspectives
    Gonzalez, Arantxa
    Schelbert, Erik B.
    Diez, Javier
    Butler, Javed
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (15) : 1696 - 1706
  • [10] Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
    Hou, Yi-Chou
    Zheng, Cai-Mei
    Yen, Tzung-Hai
    Lu, Kuo-Cheng
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 25